Physician profile
Thomas Patrick Mcbride
NPI 1174515209
$1,557.35
in general payments reported to CMS, 2019-2025
13 companies · $956 in 2025
The $956 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.99 · 2022: $274 · 2023: $42.70 · 2024: $185 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $520.94 | 2021-2025 | Xtandi |
| Endo USA, INC. | $269.57 | 2024-2025 | Xiaflex, Aveed |
| Dendreon Pharmaceuticals LLC | $142.45 | 2024-2025 | Provenge |
| Janssen Biotech, INC. | $130.01 | 2024-2025 | Carvykti, Rybrevant, Erleada |
| Pfizer INC. | $121.51 | 2024-2025 | |
| Telix Pharmaceuticals | $80.48 | 2025 | Illuccix |
| Ferring Pharmaceuticals INC. | $78.24 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $65.80 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $50.75 | 2024-2025 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $42.89 | 2024-2025 | |
| Medtronic, INC. | $19.84 | 2025 | Altaviva |
| Procept Biorobotics Corporation | $19.72 | 2025 | |
| Olympus America INC. | $15.15 | 2025 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.